|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 面向21世纪的卒中新定义:美国心脏病学会和美国卒中学会声明显示文摘尽管脑血管病有着全球性影响且对其病理生理学的认识有了很多进步,但是'卒中'这一术语在临床实践、临床研究或公共卫生评估中的定义却不一致。传统的定义依据于临床,却没有考虑到科学技术的进步。美国心脏协会(AHA)和美国卒中协会(ASA)卒中分会组织了写作小组,为21世纪卒中新定义撰写专家共识性声明。中枢神经系统(CNS)梗死,指由缺血所导致的脑、脊髓或视网膜的细胞死亡,是基于持续性损害的神经病理学、神经影像学和(或)临床证据。CNS梗死表现为一个临床谱:缺血性卒中特指伴有明显症状的CNS梗死,而静息性梗死根据定义指未引起已知的症状的梗死。卒中也还包括脑出血和蛛网膜下腔出血。新定义的卒中结合了临床和组织学标准,可被用于实践、研究和公共卫生评估。 | 俞羚 董荃 宋叶平 江静雯 李卉 刘亮贤 苏爱萍 李焰生 Sacco RL Kasner SE Broderick JP Caplan LR Connors JJ Culebras A Elkind MS George MG Hamdan AD Higashida RT Hoh BL Janis LS Kase CS Kleindorfer DO Lee JM Moseley ME Peterson ED Turan TN Valderrama AL Vinters HV | 2013 | 神经病学与神经康复学杂志2013，10，2： | 188 |
| 2 | Use of plasma MMP-2and MMP- 9 levels as a surrogate for tumour expression in colorectal cancer patients显示文摘 | Tutton MG George ML Eccles SA | 2003 | Int J Cancer2003，107，4： | 1 |
| 3 | VEGF-A, VEGF-C, and V EGF-D in colorectal cancer progression 显示文摘 | George ML Tutton MG Janssen F | 2001 | Neoplasia2001，3，5： | 1 |
| 4 | Modulatory effects of ascorbate,alone or with haloperidol,on a lever-release conditioned avoidance response task显示文摘 | Joshua MG George RV | 1999 | Pharmacol Biochem Behav1999，63，1： | 1 |
| 5 | Correlation of plasma and serum vascular endothelial growth factor levels with platelet count in colorectal cancer: clinical evidence of platelet scavenging 显示文摘 | George ML Eccles SA Tutton MG | 2000 | Clin Cancer Res2000，6，8： | 1 |
| 6 | Trends in stroke hospi- talizations and associated risk factors among children and young adults, 1995-2008显示文摘 | George MG Tong X Kuklina EV | 2011 | Ann Neurol2011，70，： | 1 |
| 7 | Rhesus macaque lymph node PD-1 (hi)CD4 + T cells express high levels of CXCR5 and IL-21 and display a CCRT(Io)ICOS+BeI6+ T- follicular helper (Tfh) cell phenotype显示文摘 | Onabajo OO George J Lewis MG | 2013 | PLoS One2013，8，59： | 1 |
| 8 | VEGF-A, VEGF-C and VEGF-D in colorectal cancer progression 显示文摘 | George ML Tutton MG Janssen F | 2001 | Neoplasia2001，3，5： | 1 |
| 9 | VEGF-A, VEGF-C and VEGF-D in colorectal cancer progression 显示文摘 | George ML Tutton MG Janssen F | 2001 | Neoplasia2001，3，： | 1 |
| 10 | VEGF-A, VEGF-C and VEGF-D in colorectal cancer progression 显示文摘 | George ML Tutton MG Janssen F | 2001 | Neoplasia2001，3，5： | 1 |
| 11 | Impotence after mesorectal and close rectal dissection for inflammatory bowel disease显示文摘 | Lindsey I George BD Kettlewell MG | 2001 | Dis Colon Rectum2001，44，6： | 1 |
| 12 | Use of plasma mmp-2 and-9 levels as a surrogate for tumor expression in colorectal cancer patients显示文摘 | Tutton MG George ML Eccles SA | 2003 | Int J Cancer2003，107，4： | 1 |
| 13 | Use of plasma MMP-2 and MMP-9 levels as a surrogate for tumour expression in colorectal cancer patients 显示文摘 | Tutton MG George ML Eccles SA | 2003 | Int J Cancer2003，107，4： | 1 |
| 14 | Modulatory effects of ascorbate, alone or with haloperidol, on a lever-release conditioned avoidance response task 显示文摘 | Joshua MG George RV | 1999 | Pharmacol Biochem Behav1999，63，1： | 1 |
| 15 | VEGF - A, VEGF - C and VEGF - D in colorectal cancer progression 显示文摘 | George ML Tutton MG Janssen F etal | 2001 | Neoplasia2001，3，5： | 1 |
| 16 | Modeling spatial means of surfaces with stratified nonhomogeneity 显示文摘 | Wang JF George C Hu MG | 2009 | IEEE T Geosci Remote2009，47，12： | 1 |
| 17 | VEGF-A, VEGF-C, and VEGF-D in colorectal cancer progression显示文摘 | George ML Tutton MG Janssen F | 2001 | Neoplasia2001，3，5： | 1 |
| 18 | VEGF-A,VEGF-C,and VEGF-D in colorectal cancer progression显示文摘 | George ML Tutton MG Janssen F | 2001 | Neoplasia2001，3，5： | 1 |
| 19 | Use of plasma MMP-2 and MMP-9 levels as a surrogate for tumour expression in colorectal cancer patients 显示文摘 | George ML Eccles SA | 2003 | Int J Cancer2003，107，4： | 1 |
| 20 | VEGF-A,VEGF-C,and VEGF-D in colorectal cancer pro-gression显示文摘 | George ML Tutton MG Janssen F | 2001 | Neoplasia2001，3，5： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员